In breast cancer, an increase in Tregs population both in peripheral blood and tumor tissues was also reported [25] and a recent study demonstrated a significant intratumoral infiltration of FOXP3+ Tregs in high-risk breast cancer patients and those at risk of late relapse [26]. The gene discussed is FOXP3; the disease is breast carcinoma.